David Setboun
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Setboun
Earlier roles on record: COO at Brainstorm Cell Therapeutics Inc. (BCLI) until May 31, 2023. Brainstorm Cell Therapeutics Inc. reported in an 8-K filed May 24, 2023 that David Setboun resigned as Executive Vice President and Chief Operating Officer, effective May 31, 2023. David Setboun has spoken on 5 earnings calls across 1 company, most recently for Brainstorm Cell Therapeutics Inc. on March 30, 2023.
“On May 18, 2023, David Setboun, PhD, MBA, Executive Vice President and Chief Operating Officer of Brainstorm Cell Therapeutics Inc. (the "Company"), notified the Company of his decision to resign from his role effective as of May 31, 2023 to pursue another opportunity.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-05-31
-
Start not stated–2023-05-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.